Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia

Biological Psychiatry

Volumn 55, Issue 3, 2004, Pages 225-233

  López Figueroa, Antonio L ^a   Norton, Camille S ^a   López Figueroa, Manuel O ^a   Armellini Dodel, Denise ^a   Burke, Sharon ^a   Akil, Huda ^a   López, Juan F ^a   Watson, Stanley J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Dorsolateral prefrontal cortex; Hippocampus; In situ hybridization; Mood disorder; mRNA; Serotonin receptors

Indexed keywords

MESSENGER RNA; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR;

ADULT; ANAMNESIS; ARTICLE; BIPOLAR DISORDER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; NUCLEOTIDE SEQUENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HIPPOCAMPUS; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PREFRONTAL CORTEX; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT2A; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 1642441801     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2003.09.017     Document Type: Article

References (78)

1. Arango V., Ernsberger P., Marzuk P.M., Chen J.S., Tierney H., Stanley M., et al. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry. 47:1990;1038-1047.
2. Arango V., Underwood M.D., Gubbi A.V., Mann J.J. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 688:1995;121-133.
3. Arora R.C., Meltzer H.Y. Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients. J Neural Transm Gen Sect. 85:1991;19-29.
4. Arranz B., Eriksson A., Mellerup E., Plenge P., Marcusson J. Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biol Psychiatry. 35:1994;457-463.
5. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 38:1999;1083-1152.
6. Benes F.M., Kwok E.W., Vincent S.L., Todtenkopf M.S. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry. 44:1998;88-97.
7. Bruinvels A.T., Landwehrmeyer B., Gustafson E.L., Durkin M.M., Mengod G., Branchek T.A., et al. Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology. 33:1994;367-386.
8. Bunney W.E. Jr, Davis J.M. Norepinephrine in depressive reactions. A review. Arch Gen Psychiatry. 13:1965;483-494.
9. 2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology. 15:1996;442-455.
10. Burnet P.W., Eastwood S.L., Lacey K., Harrison P.J. The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain. Brain Res. 676:1995;157-168.
11. Butler M.O., Morinobu S., Duman R.S. Chronic electroconvulsive seizures increase the expression of serotonin2 receptor mRNA in rat frontal cortex. J Neurochem. 61:1993;1270-1276.
12. Chalmers D.T., Kwak S.P., Mansour A., Akil H., Watson S.J. Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression. J Neurosci. 13:1993;914-923.
13. Chalmers D.T., López J.F., Vazquez D.M., Akil H., Watson S.J. Regulation of hippocampal 5-HT1A receptor gene expression by dexamethasone. Neuropsychopharmacology. 10:1994;215-222.
14. Cheetham S.C., Crompton M.R., Katona C.L., Horton R.W. Brain 5-HT1 binding sites in depressed suicides. Psychopharmacology. 102:1990;544-548.
15. Chen G., Rajkowska G., Du F., Seraji-Bozorgzad N., Manji H.K. Enhancement of hippocampal neurogenesis by lithium. J Neurochem. 75:2000;1729-1734.
16. Dean B., Hayes W. Decreased frontal cortical serotonin2A receptors in schizophrenia. Schizophr Res. 21:1996;133-139.
17. Dean B., Hayes W., Hill C., Copolov D. Decreased serotonin2A receptors in Brodmann's area 9 from schizophrenic subjects. A pathological or pharmacological phenomenon? Mol Chem Neuropathol. 34:1998;133-145.
18. Dean B., Hussain T., Hayes W., Scarr E., Kitsoulis S., Hill C., et al. Changes in serotonin2A and GABA(A) receptors in schizophrenia Studies on the human dorsolateral prefrontal cortex . J Neurochem. 72:1999;1593-1599.
19. Dean B., Pavey G., McLeod M., Opeskin K., Keks N., Copolov D. A change in the density of[(3)H] [(3)H]flumazenil, but not [(3)H] [(3)H]muscimol binding, in Brodmann's area 9 from subjects with bipolar disorder. J Affect Disord. 66:2001;147-158.
20. Dean B., Tomaskovic-Crook E., Opeskin K., Keks N., Copolov D. No change in the density of the serotonin1A receptor, the serotonin4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia. Neurochem Int. 34:1999;109-115.
21. Deutch A., Roth R. Neurotransmitters. Zigmond M. Fundamental Neuroscience. 1999;208-212 Academic Press, San Diego.
22. Done C.J., Sharp T. Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors Microdialysis studies in the awake and anaesthetized rat . Neuropharmacology. 33:1994;411-421.
23. Farber N.B., Hanslick J., Kirby C., McWilliams L., Olney J.W. Serotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity. Neuropsychopharmacology. 18:1998;57-62.
24. Fargin A., Raymond J.R., Lohse M.J., Kobilka B.K., Caron M.G., Lefkowitz R.J. The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature. 335:1988;358-360.
25. Gold P.W., Goodwin F.K., Chrousos G.P. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress. N Eng J Med. 319:1988;413-420.
26. Hartig P.R., Hoyer D., Humphrey P.P., Martin G.R. Alignment of receptor nomenclature with the human genome Classification of 5-HT1B and 5-HT1D receptor subtypes . Trends Pharmacol Sci. 17:1996;103-105.
27. 1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. Life Sci. 48:1991;355-363.
28. Izumi J., Washizuka M., Miura N., Hiraga Y., Ikeda Y. Hippocampal serotonin 5-HT1A receptor enhances acetylcholine release in conscious rats. J Neurochem. 62:1994;1804-1808.
29. Jin H., Oksenberg D., Ashkenazi A., Peroutka S.J., Duncan A.M., Rozmahel R., et al. Characterization of the human 5-hydroxytryptamine1B receptor. J Biol Chem. 267:1992;5735-5738.
30. Joyce J.N., Shane A., Lexow N., Winokur A., Casanova M.F., Kleinman J.E. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology. 8:1993;315-336.
31. Knable M.B., Barci B.M., Bartko J.J., Webster M.J., Torrey E.F. Molecular abnormalities in the major psychiatric illnesses Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers . Mol Psychiatry. 7:2002;392-404.
32. Knable M.B., Torrey E.F., Webster M.J., Bartko J.J. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res Bull. 55:2001;651-659.
33. Laruelle M., Abi-Dargham A., Casanova M.F., Toti R., Weinberger D.R., Kleinman J.E. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch Gen Psychiatry. 50:1993;810-818.
34. López J.F., Chalmers D.T., Little K.Y., Watson S.J. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus Implications for the neurobiology of depression . Biol Psychiatry. 43:1998;547-573.
35. López J.F., Vazquez D.M., Chalmers D.T., Watson S.J. Regulation of 5-HT receptors and the hypothalamic-pituitary-adrenal axis. Implications for the neurobiology of suicide. Ann N Y Acad Sci. 836:1997;106-134.
36. López-Figueroa M.O., Day H.E., Lee S., Rivier C., Akil H., Watson S.J. Temporal and anatomical distribution of nitric oxide synthase mRNA expression and nitric oxide production during central nervous system inflammation. Brain Res. 852:2000;239-246.
37. Lowther S., De Paermentier F., Cheetham S.C., Crompton M.R., Katona C.L., Horton R.W. 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. J Affect Disord. 42:1997;199-207.
38. Manji H.K., Moore G.J., Rajkowska G., Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry. 5:2000;578-593.
39. Mann J.J., Stanley M., McBride P.A., McEwen B.S. Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry. 43:1986;954-959.
40. Matsubara S., Arora R.C., Meltzer H.Y. Serotonergic measures in suicide brain 5-HT1A binding sites in frontal cortex of suicide victims . J Neural Transm Gen Sect. 85:1991;181-194.
41. Meador-Woodruff J.H., Greden J.F., Grunhaus L., Haskett R.F. Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation Identification of contributing factors . Acta Psychiatr Scand. 81:1990;364-371.
42. Meijer O.C., de Kloet E.R. Corticosterone and serotonergic neurotransmission in the hippocampus Functional implications of central corticosteroid receptor diversity . Crit Rev Neurobiol. 12:1998;1-20.
43. Melzter H. Serotonergic dysfunction in depression. Br J Psychiatry. 155:1989;25-31.
44. Mendelson S.D., McEwen B.S. Autoradiographic analyses of the effects of restraint-induced stress on 5-HT1A, 5-HT1C and 5-HT2 receptors in the dorsal hippocampus of male and female rats. Neuroendocrinology. 54:1991;454-461.
45. Mendelson S.D., McEwen B.S. Autoradiographic analyses of the effects of adrenalectomy and corticosterone on 5-HT1A and 5-HT1B receptors in the dorsal hippocampus and cortex of the rat. Neuroendocrinology. 55:1992;444-450.
46. Mita T., Hanada S., Nishino N., Kuno T., Nakai H., Yamadori T., et al. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol Psychiatry. 21:1986;1407-1414.
47. Moret C., Briley M. The possible role of 5-HT(1B/D) receptors in psychiatric disorders and their potential as a target for therapy. Eur J Pharmacol. 404:2000;1-12. [review].
48. Nemeroff C.B. The neurobiology of depression. Sci Am. 278:1998;42-49.
49. Norton C.S., Neal C.R., Kumar S., Akil H., Watson S.J. Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems. J Comp Neurol. 444:2002;358-368.
50. Olney J.W., Newcomer J.W., Farber N.B. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res. 33:1999;523-533. [review].
51. Olney J.W., Newcomer J.W., Farber N.B. Is NMDA receptor hypofunction in schizophrenia associated with a primary hyperglutamatergic state? Arch Gen Psychiatry. 59:2002;466-468.
52. Pandey G.N., Dwivedi Y., Rizavi H.S., Ren X., Pandey S.C., Pesold C., et al. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry. 159:2002;419-429.
53. Pasqualetti M., Nardi I., Ladinsky H., Marazziti D., Cassano G.B. Comparative anatomical distribution of serotonin 1A, 1D alpha and 2A receptor mRNAs in human brain postmortem. Brain Res Mol Brain Res. 39:1996;223-233.
54. Pazos A., Probst A., Palacios J.M. Serotonin receptors in the human brain - III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience. 21:1987;97-122.
55. Pazos A., Probst A., Palacios J.M. Serotonin receptors in the human brain-IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience. 21:1987;123-139.
56. Peroutka S.J., Snyder S.H. Regulation of serotonin2 (5-HT2) receptors labeled with. [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline J Pharmacol Exp Ther. 215:1980;582-587.
57. Pompeiano M., Palacios J.M., Mengod G. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain Correlation with receptor binding . J Neurosci. 12:1992;440-453.
58. Pompeiano M., Palacios J.M., Mengod G. Distribution of the serotonin 5-HT2 receptor family mRNAs Comparison between 5-HT2A and 5-HT2C receptors . Brain Res Mol Brain Res. 23:1994;163-178.
59. Prange A.J. Jr, Wilson I.C., Lynn C.W., Alltop L.B., Stikeleather R.A. L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders. Arch Gen Psychiatry. 30:1974;56-62.
60. Price L.H., Charney D.S., Delgado P.L., Heninger G.R. Lithium and serotonin function Implications for the serotonin hypothesis of depression . Psychopharmacology. 100:1990;3-12.
61. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry. 48:2000;766-777.
62. Rajkowska G., Halaris A., Selemon L.D. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry. 49:2001;741-752.
63. Reynolds G.P., Rossor M.N., Iversen L.L. Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action. J Neural Transm Suppl. 18:1983;273-277.
64. Sawa A., Snyder S.H. Schizophrenia Diverse approaches to a complex disease . Science. 296:2002;692-695.
65. Scarr E., Copolov D.L., Dean B. A proposed pathological model in thehippocampus of subjects with schizophrenia. Clin Exp Pharmacol Physiol. 28:2001;70-73.
66. Shiah I.S., Yatham L.N. Serotonin in mania and in the mechanism of action of mood stabilizers A review of clinical studies . Bipolar Disord. 2:2000;77-92.
67. Silbersweig D.A., Stern E., Frith C., Cahill C., Holmes A., Grootoonk S., et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature. 378:1995;176-179.
68. Simpson M.D., Lubman D.I., Slater P., Deakin J.F. Autoradiography with. [3H]8-OH-DPAT reveals increases in 5-HT(1A) receptors in ventral prefrontal cortex in schizophrenia Biol Psychiatry. 39:1996;919-928.
69. Stockmeier C.A. Neurobiology of serotonin in depression and suicide. Ann N Y Acad Sci. 836:1997;220-232.
70. Stockmeier C.A., Dilley G.E., Shapiro L.A., Overholser J.C., Thompson P.A., Meltzer H.Y. Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology. 16:1997;162-173.
71. Sumiyoshi T., Stockmeier C.A., Overholser J.C., Dilley G.E., Meltzer H.Y. Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Res. 708:1996;209-214.
72. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The Stanley Foundation Brain Collection and Neuropathology Consortium. Schizophr Res. 44:2000;151-155.
73. Van der Zee E.A., Luiten P.G. GABAergic neurons of the rat dorsal hippocampus express muscarinic acetylcholine receptors. Brain Res Bull. 32:1993;601-609.
74. Vawter M.P., Freed W.J., Kleinman J.E. Neuropathology of bipolar disorder. Biol Psychiatry. 48:2000;486-504.
75. Watson S.J., Patel P., Burke S., Herman J., Schafer M., Kwak S. In situ hybridization of mRNA in nervous tissue: A primer. Sundermann A. Short Course 1 Syllabus. 1988;4-29 Society for Neuroscience, Washington, DC.
76. Weinshank R.L., Zgombick J.M., Macchi M.J., Branchek T.A., Hartig P.R. Human serotonin 1D receptor is encoded by a subfamily of two distinct genes 5-HT1D alpha and 5-HT1D beta . Proc Natl Acad Sci U S A. 89:1992;3630-3634.
77. Whitaker PM, Crow TJ, Ferrier IN Tritiated (1981): LSD binding in frontal cortex in schizophrenia. Arch Gen Psychiatry 38:278-280.
78. López J.F., Akil H., Watson S.J. Neural circuits mediating stress. Biol Psychiatry. 46:1999;1461-1471. [review].